Sprinklr CXM 深 沪
已收盘 08-01 16:00:00 美东时间
8.58
-0.430
-4.77%
华盛通- 最 高8.885
- 今 开8.86
- 成交量 192.39万股
- 最 低 8.56
- 昨 收 9.01
- 总市值 22.22亿
- 52周最高 9.685
- 市盈率 静 19.39
- 换手率 0.74%
- 52周最低 6.75
- 委 比 -83.33%
- 总股本 2.59亿
- 历史最高 26.50
- 量 比 1.07
- 振 幅 3.61%
- 历史最低 6.75
- 每 手 1
- 风险率 0.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sprinklr Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)
Sprinklr (NYSE:CXM) underwent analysis by 10 analysts in the last quarter, reve...
06-27 21:01
Sprinklr Announces Departure of Chief Customer Officer
Sprinklr ( ($CXM) ) has shared an update. On June 24, 2025, Sprinklr, Inc. anno...
06-25 05:49
美股大行评级 | 潜在涨幅6326.33%！Ascendiant Capital上调Plus Therapeutics目标价至20.5美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1137665801621229569.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持Plus Therapeutics(PSTV)"买入"评级，目标价从20美元升至20.5美元</p> <p>• Ascendiant Capital：维持RenovoRx(RNXT
06-06 09:45
Sprinklr Analysts Boost Their Forecasts After Upbeat Earnings
Sprinklr, Inc (NYSE:CXM) reported better-than-expected fiscal first-quarter 202...
06-06 04:12
Sprinklr Eyes Long-Term Growth With 'Project Bear Hug' Despite Customer Churn Concerns: Analyst
Catharine Trebnick maintains Buy on Sprinklr with $12 price target. Company shows progress despite customer churn and down-sell issues.
06-06 01:02
Rosenblatt Maintains Buy on Sprinklr, Maintains $12 Price Target
Rosenblatt analyst Catharine Trebnick maintains Sprinklr (NYSE:CXM) with a Buy and maintains $12 price target.
06-05 19:15
电话会总结 ｜ Sprinklr Q1 2026 业绩电话会核心要点
<span> <meta content="no-referrer" name="referrer"></span><span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote> <p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• **财务业绩**： - 总营收为2.055亿美元，同比增长5%。 - 订阅收入为1.841亿美元，同比增长4%。 - 专业服务收入为2140万美元。 - 非GAAP运营收入为3670万美元，非GAAP运营利润率为18%。 - 自由现金流为8070万美元，若加回重组支付的1180万美元，自由现金流为9250万美元。 - 现金及有价证券总额为5.702亿美元，公司无债务。</p> <p>• **财务指标变化**： - 总营收同比增长5%
06-05 12:07
D.A. Davidson Sticks to Their Hold Rating for Sprinklr (CXM)
In a report released yesterday, Clark Wright from D.A. Davidson maintained a Ho...
06-05 08:25
What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained
Cellectar's Iopofosine I 131 earned FDA breakthrough therapy designation for relapsed Waldenstrom macroglobulinemia following strong trial data.
06-05 00:35
Sprinklr outlines $825M–$827M FY26 revenue target while expanding AI platform and launching $150M buyback
Earnings Call Insights: Sprinklr, Inc. (CXM) Q1 2026 Management View President and CEO Rory P. Read reported "first quarter total revenue grew 5% year-over-year to $205.5 million, and subscription rev...
06-05 00:09
